Results 11 to 20 of about 258,864 (309)

The spatial analysis of diagnosed Chronic Kidney Disease in Nigeria: A case study of Edo State [PDF]

open access: yes, 2012
The thesis explores the severity of diagnosed chronic kidney disease (CKD) with particular reference to its impact in Edo state, Nigeria. There has been a scarcity of studies on the prevalence and spatial patterns of CKD in developing countries even ...
Oviasu, Osaretin
core   +6 more sources

Pharmacogenomics of Hypertension in CKD: The CKD-PGX Study [PDF]

open access: yesKidney360, 2022
Key Points The CKD-PGX study assessed the feasibility of pharmacogenomic testing for a panel of antihypertensive agent efficacy predictors.
Michael T. Eadon   +11 more
openaire   +2 more sources

Slowing Progression in CKD [PDF]

open access: yesClinical Journal of the American Society of Nephrology, 2021
There is a recognized large global burden of CKD ([1][1]). With the projected rise in prevalence of diabetes in coming years, that burden may indeed increase. Thus, the need for therapies to slow the progression of CKD, and its attendant comorbidities, is critical.
Kathryn, Larmour, Adeera, Levin
openaire   +2 more sources

Constipation in CKD [PDF]

open access: yesKidney International Reports, 2020
Constipation is one of the most common gastrointestinal disorders among patients with chronic kidney disease (CKD) partly because of their sedentary lifestyle, low fiber and fluid intake, concomitant medications (e.g., phosphate binders), and multiple comorbidities (e.g., diabetes).
Keiichi Sumida   +2 more
openaire   +3 more sources

Phosphate, Microbiota and CKD [PDF]

open access: yesNutrients, 2021
Phosphate is a key uremic toxin associated with adverse outcomes. As chronic kidney disease (CKD) progresses, the kidney capacity to excrete excess dietary phosphate decreases, triggering compensatory endocrine responses that drive CKD-mineral and bone disorder (CKD-MBD).
Chiara Favero   +8 more
openaire   +3 more sources

Storytelling for impact: the creation of a storytelling program for patient partners in research

open access: yesResearch Involvement and Engagement, 2023
Storytelling is a powerful means to evoke empathy and understanding among people. When patient partners, which include patients, family members, caregivers and organ donors, share their stories with health professionals, this can prompt listeners to ...
Leah E. Getchell   +14 more
doaj   +1 more source

Inhibition of histone deacetylase 6 suppresses inflammatory responses and invasiveness of fibroblast-like-synoviocytes in inflammatory arthritis

open access: yesArthritis Research & Therapy, 2021
Background To investigate the effects of inhibiting histone deacetylase (HDAC) 6 on inflammatory responses and tissue-destructive functions of fibroblast-like synoviocytes (FLS) in rheumatoid arthritis (RA).
Jin Kyun Park   +11 more
doaj   +1 more source

CKD ANAEMIA [PDF]

open access: yesNephrology Dialysis Transplantation, 2014
International ...
J. Fernandes   +125 more
openaire   +3 more sources

Ensuring Indigenous co-leadership in health research: a Can-SOLVE CKD case example

open access: yesInternational Journal for Equity in Health, 2023
Background Indigenous people are insightful and informed about their own health and wellness, yet their visions, strengths and knowledge are rarely incorporated into health research.
Cathy Woods   +22 more
doaj   +1 more source

Program Report: Can-SOLVE CKD Network Presents an Inclusive Method for Developing Patient-Oriented Research Tools

open access: yesCanadian Journal of Kidney Health and Disease, 2022
Purpose of program: Given the growing interest in patient-oriented research (POR) initiatives, there is a need to provide relevant training and education on how to engage with patients as partners on research teams. Sources of information: As part of its
Leah E. Getchell   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy